Your browser doesn't support javascript.
loading
Early Th2 inflammation in the upper respiratory mucosa as a predictor of severe COVID-19 and modulation by early treatment with inhaled corticosteroids: a mechanistic analysis.
Baker, Jonathan R; Mahdi, Mahdi; Nicolau, Dan V; Ramakrishnan, Sanjay; Barnes, Peter J; Simpson, Jodie L; Cass, Steven P; Russell, Richard E K; Donnelly, Louise E; Bafadhel, Mona.
Afiliação
  • Baker JR; National Heart and Lung Institute, Imperial College London, London, UK.
  • Mahdi M; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Nicolau DV; Nuffield Department of Medicine, University of Oxford, Oxford, UK; UQ Centre for Clinical Research, The University of Queensland, Brisbane, QLD, Australia; School of Mathematical Sciences, Queensland University of Technology, Brisbane, QLD Australia.
  • Ramakrishnan S; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; School of Medical and Health Sciences, Edith Cowan University, Perth, WA, Australia.
  • Barnes PJ; National Heart and Lung Institute, Imperial College London, London, UK.
  • Simpson JL; School of Medicine and Public Health, Priority Centre for Healthy Lungs, University of Newcastle, Callaghan, NSW, Australia.
  • Cass SP; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Russell REK; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Donnelly LE; National Heart and Lung Institute, Imperial College London, London, UK.
  • Bafadhel M; National Institute for Health Research Oxford Biomedical Research Centre, Oxford, UK; Nuffield Department of Medicine, University of Oxford, Oxford, UK; School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, UK. Electronic address: mona.baf
Lancet Respir Med ; 10(6): 545-556, 2022 06.
Article em En | MEDLINE | ID: mdl-35397798
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Respir Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Lancet Respir Med Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido